Share on StockTwits

Merge Healthcare (NASDAQ:MRGE) Director William J. Devers, Jr. acquired 10,000 shares of the company’s stock on the open market in a transaction that occurred on Wednesday, June 4th. The shares were purchased at an average cost of $2.08 per share, with a total value of $20,800.00. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link.

Merge Healthcare (NASDAQ:MRGE) opened at 2.20 on Friday. Merge Healthcare has a 52-week low of $1.97 and a 52-week high of $4.71. The stock has a 50-day moving average of $2.22 and a 200-day moving average of $2.31. The company’s market cap is $208.4 million.

Merge Healthcare (NASDAQ:MRGE) last released its earnings data on Wednesday, April 30th. The company reported $0.04 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.04. The company had revenue of $50.90 million for the quarter, compared to the consensus estimate of $52.49 million. During the same quarter in the prior year, the company posted ($0.01) earnings per share. The company’s quarterly revenue was down 20.0% on a year-over-year basis. On average, analysts predict that Merge Healthcare will post $0.10 earnings per share for the current fiscal year.

Separately, analysts at Zacks downgraded shares of Merge Healthcare from a “neutral” rating to an “underperform” rating in a research note on Monday, March 24th. They now have a $2.25 price target on the stock.

Merge Healthcare Incorporated (NASDAQ:MRGE) develops software solutions that facilitate the sharing of images to create an electronic healthcare experience for patients and physicians.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.